Security key
152309100
Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA)
CUSIP: 152309100
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares, nominal value GBP 0.002 per share
- Shares outstanding
- 154,150,943
- Total 13F shares
- 86,506,981
- Share change
- +12,111,714
- Total reported value
- $781,158,600
- Put/Call ratio
- 25%
- Price per share
- $9.03
- Number of holders
- 79
- Value change
- +$108,671,569
- Number of buys
- 43
- Number of sells
- 25
Report period
Q2 2024
Institutions
79
Top holders
10
CNTA full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Centessa Pharmaceuticals plc SEC filings
Centessa Pharmaceuticals plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 152309100
Recent filing periods:
Ownership snapshot
Top shareholders of CNTA - Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
Lead holder
Medicxi Ventures Management (Jersey) Ltd
13D/G signal
—
Evidence rows
50
Latest as of
31 Mar 2024
13F
3/4/5
Lead comparable stake: 13%
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
Company · 10%+ Owner
|
13%
|
$225,583,674
19,963,157 shares
|
— | 31 Mar 2024 |
| GENERAL ATLANTIC, L.P. |
13F
Company
|
6.3%
|
$109,404,543
9,681,818 shares
|
— | 31 Mar 2024 |
| EcoR1 Capital, LLC |
13F
Company
|
3.6%
|
$63,492,203
5,618,779 shares
|
— | 31 Mar 2024 |
| Vida Ventures Advisors, LLC |
13F
Company
|
2.6%
|
$44,429,544
3,931,818 shares
|
— | 31 Mar 2024 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
2%
|
$34,841,369
3,083,307 shares
|
— | 31 Mar 2024 |
| First Light Asset Management, LLC |
13F
Company
|
1.9%
|
$33,923,109
3,002,045 shares
|
— | 31 Mar 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
1.9%
|
$33,427,000
2,958,079 shares
|
— | 31 Mar 2024 |
| FMR LLC |
13F
Company
|
1.8%
|
$31,495,292
2,787,194 shares
|
— | 31 Mar 2024 |
| Point72 Asset Management, L.P. |
13F
Company
|
1.5%
|
$25,512,213
2,257,718 shares
|
— | 31 Mar 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
1.5%
|
$25,425,000
2,250,000 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
1.4%
|
$24,152,225
2,137,365 shares
|
— | 31 Mar 2024 |
| Octagon Capital Advisors LP |
13F
Company
|
1.3%
|
$23,279,130
2,060,100 shares
|
— | 31 Mar 2024 |
| TCG Crossover Management, LLC |
13F
Company
|
1.3%
|
$23,061,221
2,040,816 shares
|
— | 31 Mar 2024 |
| Artal Group S.A. |
13F
Company
|
0.92%
|
$15,961,250
1,412,500 shares
|
— | 31 Mar 2024 |
| 5AM Venture Management, LLC |
13F
Company
|
0.81%
|
$14,068,500
1,245,000 shares
|
— | 31 Mar 2024 |
| FRANKLIN RESOURCES INC |
13F
Company
|
0.75%
|
$13,070,970
1,156,723 shares
|
— | 31 Mar 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
Company
|
0.72%
|
$12,475,358
1,104,014 shares
|
— | 31 Mar 2024 |
| AMERICAN CENTURY COMPANIES INC |
13F
Company
|
0.6%
|
$10,431,267
923,120 shares
|
— | 31 Mar 2024 |
| Affinity Asset Advisors, LLC |
13F
Company
|
0.54%
|
$9,385,170
830,546 shares
|
— | 31 Mar 2024 |
| Tanager Wealth Management LLP |
13F
Company
|
0.45%
|
$7,865,885
696,096 shares
|
— | 31 Mar 2024 |
| Cormorant Asset Management, LP |
13F
Company
|
0.36%
|
$6,346,080
561,600 shares
|
— | 31 Mar 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
Company
|
0.31%
|
$5,482,466
485,174 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
0.25%
|
$4,321,821
382,462 shares
|
— | 31 Mar 2024 |
| ExodusPoint Capital Management, LP |
13F
Company
|
0.25%
|
$4,286,000
379,314 shares
|
— | 31 Mar 2024 |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
Company
|
0.24%
|
$4,192,300
371,000 shares
|
— | 31 Mar 2024 |
| PFM Health Sciences, LP |
13F
Company
|
0.2%
|
$3,555,816
314,674 shares
|
— | 31 Mar 2024 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
0.19%
|
$3,247,541
287,393 shares
|
— | 31 Mar 2024 |
| Exome Asset Management LLC |
13F
Company
|
0.18%
|
$3,106,370
274,900 shares
|
— | 31 Mar 2024 |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
Company
|
0.17%
|
$2,875,240
254,446 shares
|
— | 31 Mar 2024 |
| MARSHALL WACE, LLP |
13F
Company
|
0.15%
|
$2,616,685
231,565 shares
|
— | 31 Mar 2024 |
| TD ASSET MANAGEMENT INC |
13F
Company
|
0.15%
|
$2,583,677
228,644 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.14%
|
$2,472,000
218,800 shares
|
— | 31 Mar 2024 |
| ADAR1 Capital Management, LLC |
13F
Company
|
0.13%
|
$2,337,473
206,856 shares
|
— | 31 Mar 2024 |
| Ensign Peak Advisors, Inc |
13F
Company
|
0.08%
|
$1,414,274
125,157 shares
|
— | 31 Mar 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
Company
|
0.07%
|
$1,220,942
108,048 shares
|
— | 31 Mar 2024 |
| Trexquant Investment LP |
13F
Company
|
0.06%
|
$1,090,800
96,531 shares
|
— | 31 Mar 2024 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
Company
|
0.06%
|
$1,019,712
90,240 shares
|
— | 31 Mar 2024 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
0.05%
|
$890,225
78,781 shares
|
— | 31 Mar 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.05%
|
$869,919
76,984 shares
|
— | 31 Mar 2024 |
| Cubist Systematic Strategies, LLC |
13F
Company
|
0.05%
|
$820,482
72,609 shares
|
— | 31 Mar 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.04%
|
$780,932
69,109 shares
|
— | 31 Mar 2024 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.04%
|
$621,805
55,027 shares
|
— | 31 Mar 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.03%
|
$530,738
46,968 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.02%
|
$378,990
33,539 shares
|
— | 31 Mar 2024 |
| Jump Financial, LLC |
13F
Company
|
0.02%
|
$371,465
32,873 shares
|
— | 31 Mar 2024 |
| Rathbones Group PLC |
13F
Company
|
0.02%
|
$353,690
31,300 shares
|
— | 31 Mar 2024 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
0.02%
|
$330,000
29,409 shares
|
— | 31 Mar 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
0.02%
|
$308,095
27,265 shares
|
— | 31 Mar 2024 |
| Lynx1 Capital Management LP |
13F
Company
|
0.01%
|
$196,620
17,400 shares
|
— | 31 Mar 2024 |
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
0.01%
|
$154,000
13,587 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
79
Shares
86,506,981
Rows loaded
79
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
69
Q2 2024 holders
79
Holder diff
10
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.